Case of Anakinra as a Steroid-Sparing Agent for Gout Inflammation

被引：39

作者：

Gratton, Sarah B. ^{[1
]}

Scalapino, Kenneth J. ^{[1
,2
]}

Fye, Kenneth H. ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

[2] San Francisco VA Med Ctr, Arthritis Sect, San Francisco, CA USA

来源：

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2009年 / 61卷 / 09期

关键词：

IL-1;

D O I：

10.1002/art.24694

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1268 / 1270

页数：3

共 6 条

[1] Pathogenesis of gout
Choi, HK
Mount, DB
Reginato, AM
[J]. ANNALS OF INTERNAL MEDICINE, 2005, 143 (07) : 499 - 516
[2] Blocking IL-1 in systemic inflammation
Dinarello, CA
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (09) : 1355 - 1359
[3] Efficacy and safety of rilonacept (Interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes
Hoffman, Hal M.
Throne, Martin L.
Amar, N. J.
Sebai, Mohamed
Kivitz, Alan J.
Kavanaugh, Arthur
Weinstein, Steven P.
Belomestnov, Pavel
Yancopoulos, George D.
Stahl, Neil
Mellis, Scott J.
[J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (08): : 2443 - 2452
[4] The inflammasome, autoinflammatory diseases, and gout
Petrilli, Virginie
Martinon, Fabio
[J]. JOINT BONE SPINE, 2007, 74 (06) : 571 - 576
[5] A pilot study of IL-1 inhibition by anakinra in acute gout
So, Alexander
De Smedt, Thibaut
Revaz, Sylvie
Tschopp, Joerg
[J]. ARTHRITIS RESEARCH & THERAPY, 2007, 9 (02)
[6] Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout - Results of a phase II randomized study
Sundy, John S.
Becker, Michael A.
Baraf, Herbert S. B.
Barkhuizen, Andre
Moreland, Larry W.
Huang, William
Waltrip, Royce W., II
Maroli, Allan N.
Horowitz, Zeb
[J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : 2882 - 2891